Gene therapy developers see an expanded viral toolbox

Being a gene therapy developer, Batavia Biosciences' Global Technical Director, Alfred Luitjens was interviewed topic by GEN.
Batavia Biosciences - Favicon

There are still many challenges in gene therapy analytics and manufacturing according to gene therapy developers. Our Global Technical Director,  Alfred Luitjens  was interviewed on this topic by Genetic Engineering & Biotechnology News. The interview was in response to his presentation on the manufacturing of a lentiviral vector for a gene therapy against RAG1-SCID at the PepTalk conference 2020.

Link to  full  article.

Related

Viral Vector Production Guide

Bringing a new viral vector-based therapy from lab to market? This resource guides you through the complexities of viral vector development, scale-up, and cGMP manufacturing.

Low-cost viral vector manufacturing

High-throughput screening for viral vectors

Viral vector manufacturing

Thermostable viral envelope protein formulation

Maximizing protein expression